Search research articles
Contact Us
Filters
Showing results (161-170 of 178) with videos related to
Page
of 18
Sort By:
Brain Research
|
November 24, 1998
Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction
C C Meltzer, G Smith, J C Price, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 26, 2016
Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling
Romany A N Johnpulle, Sophie Paczesny, Dae Kwang Jung, et al.
Haematologica
|
January 29, 2016
Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation
Brian G Engelhardt, Sophie Paczesny, Dae Kwang Jung, et al.
Leukemia & Lymphoma
|
September 6, 2007
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes
Brian G Engelhardt, Derek W Holland, Stephen J Brandt, et al.
Leukemia & Lymphoma
|
June 12, 2019
Clinicopathologic correlates of <i>MYD88</i> L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma
Tarsheen K Sethi, Alexandra E Kovach, Natalie S Grover, et al.
Leukemia & Lymphoma
|
October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant Group
D R Fleming, S N Wolff, J W Fay, et al.
Bone Marrow Transplantation
|
April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia
Z S Pavletic, E R Arrowsmith, P J Bierman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
Prevention and treatment of cancer-related infections
Lindsey Robert Baden, William Bensinger, Michael Angarone, et al.
Acta Haematologica
|
July 18, 2019
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry
Frederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.
Blood Advances
|
February 11, 2026
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALL
Kristen M O'Dwyer, Lena E Winestone, Matthew C Cheung, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 178) with videos related to
Sort By:
Page
of 18
Brain Research
|
November 24, 1998
Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction
C C Meltzer, G Smith, J C Price, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 26, 2016
Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling
Romany A N Johnpulle, Sophie Paczesny, Dae Kwang Jung, et al.
Haematologica
|
January 29, 2016
Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation
Brian G Engelhardt, Sophie Paczesny, Dae Kwang Jung, et al.
Leukemia & Lymphoma
|
September 6, 2007
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes
Brian G Engelhardt, Derek W Holland, Stephen J Brandt, et al.
Leukemia & Lymphoma
|
June 12, 2019
Clinicopathologic correlates of <i>MYD88</i> L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma
Tarsheen K Sethi, Alexandra E Kovach, Natalie S Grover, et al.
Leukemia & Lymphoma
|
October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant Group
D R Fleming, S N Wolff, J W Fay, et al.
Bone Marrow Transplantation
|
April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia
Z S Pavletic, E R Arrowsmith, P J Bierman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
Prevention and treatment of cancer-related infections
Lindsey Robert Baden, William Bensinger, Michael Angarone, et al.
Acta Haematologica
|
July 18, 2019
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry
Frederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.
Blood Advances
|
February 11, 2026
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALL
Kristen M O'Dwyer, Lena E Winestone, Matthew C Cheung, et al.
Page
of 18